262 related articles for article (PubMed ID: 17391391)
1. Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan.
Otsuka T; Zaraket H; Takano T; Saito K; Dohmae S; Higuchi W; Yamamoto T
Clin Microbiol Infect; 2007 Mar; 13(3):325-7. PubMed ID: 17391391
[TBL] [Abstract][Full Text] [Related]
2. erm(C) is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece.
Spiliopoulou I; Petinaki E; Papandreou P; Dimitracopoulos G
J Antimicrob Chemother; 2004 May; 53(5):814-7. PubMed ID: 15056638
[TBL] [Abstract][Full Text] [Related]
3. Correlation of agar dilution and VITEK2 system for detection of resistance to macrolides, lincosamides and pristinamycin among Staphylococcus aureus and Staphylococcus epidermidis: association with genotypes.
Bémer P; Juvin ME; Corvec S; Ros A; Drugeon H
Clin Microbiol Infect; 2005 Aug; 11(8):656-61. PubMed ID: 16008619
[TBL] [Abstract][Full Text] [Related]
4. A high frequency of macrolide-lincosamide-streptogramin resistance determinants in Staphylococcus aureus isolated in South Korea.
Kim HB; Lee B; Jang HC; Kim SH; Kang CI; Choi YJ; Park SW; Kim BS; Kim EC; Oh MD; Choe KW
Microb Drug Resist; 2004; 10(3):248-54. PubMed ID: 15383170
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. III. Novel, inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics.
Inouye Y; Morifuji K; Masumi N; Sugiyama M; Takesue Y; Kodama T; Yokoyama T
Hiroshima J Med Sci; 1993 Sep; 42(3):101-7. PubMed ID: 8253604
[TBL] [Abstract][Full Text] [Related]
7. Macrolide, lincosamide and streptogramin B resistance in a dominant clone of Australian community methicillin-resistant Staphylococcus aureus.
O'Brien FG; Zaini Z; Coombs GW; Pearson JC; Christiansen K; Grubb WB
J Antimicrob Chemother; 2005 Nov; 56(5):985-6. PubMed ID: 16204342
[No Abstract] [Full Text] [Related]
8. Erythromycin-induced resistance to clindamycin in Staphylococcus aureus.
Marr JK; Lim AT; Yamamoto LG
Hawaii Med J; 2005 Jan; 64(1):6-8. PubMed ID: 15751751
[TBL] [Abstract][Full Text] [Related]
9. [Macrolide resistance phenotypes and genotypes in group G streptococci].
Açikgöz ZC; Göçer S; Almayanlar E
Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
[TBL] [Abstract][Full Text] [Related]
10. Inducible clindamycin resistance in staphylococci isolated from clinical samples.
Delialioglu N; Aslan G; Ozturk C; Baki V; Sen S; Emekdas G
Jpn J Infect Dis; 2005 Apr; 58(2):104-6. PubMed ID: 15858290
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
[TBL] [Abstract][Full Text] [Related]
12. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus.
Steward CD; Raney PM; Morrell AK; Williams PP; McDougal LK; Jevitt L; McGowan JE; Tenover FC
J Clin Microbiol; 2005 Apr; 43(4):1716-21. PubMed ID: 15814990
[TBL] [Abstract][Full Text] [Related]
13. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
Ergin A; Ercis S; Hasçelik G
J Antimicrob Chemother; 2006 Jan; 57(1):139-41. PubMed ID: 16291867
[TBL] [Abstract][Full Text] [Related]
14. Unusual inducible cross resistance to macrolides, lincosamides, and streptogramins B by methylase production in clinical isolates of Staphylococcus aureus.
Clarebout G; Nativelle E; Leclercq R
Microb Drug Resist; 2001; 7(4):317-22. PubMed ID: 11822771
[TBL] [Abstract][Full Text] [Related]
15. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
Bejuk D
Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
[TBL] [Abstract][Full Text] [Related]
16. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.
Malbruny B; Werno AM; Anderson TP; Murdoch DR; Leclercq R
J Antimicrob Chemother; 2004 Dec; 54(6):1040-4. PubMed ID: 15537693
[TBL] [Abstract][Full Text] [Related]
17. Macrolide resistance determinants of group A streptococci in Ankara, Turkey.
Acikgoz ZC; Gocer S; Tuncer S
J Antimicrob Chemother; 2003 Jul; 52(1):110-2. PubMed ID: 12805256
[TBL] [Abstract][Full Text] [Related]
18. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro.
Siberry GK; Tekle T; Carroll K; Dick J
Clin Infect Dis; 2003 Nov; 37(9):1257-60. PubMed ID: 14557972
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal activity of quinupristin-dalfopristin against strains of Staphylococcus aureus with the MLS(B) phenotype of resistance according to the erm gene type.
Clarebout G; Nativelle E; Bozdogan B; Villers C; Leclercq R
Int J Antimicrob Agents; 2004 Nov; 24(5):444-9. PubMed ID: 15519475
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp.
Fokas S; Fokas S; Tsironi M; Kalkani M; Dionysopouloy M
Clin Microbiol Infect; 2005 Apr; 11(4):337-40. PubMed ID: 15760435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
